The FPN Emerging Investigators Program
Investing in the Future of Peripheral Neuropathy Research
Breakthroughs in peripheral neuropathy research begin with great ideas and the scientists who pursue them.
The FPN Emerging Investigators Program is our commitment to funding the next generation of researchers in peripheral neuropathy—those who are dedicated to understanding, diagnosing, treating, and ultimately preventing peripheral neuropathy.
By partnering with organizations who share our research-forward mission, we’re able to invest in more promising early-career investigators through established research programs, ensuring that bold ideas and emerging talent have the support needed to move the field of peripheral neuropathy research forward.
The FPN Emerging Investigators program encourages emerging experts to develop innovative solutions for treating or preventing peripheral neuropathy. Research proposals are evaluated for their ability to address key questions and/or create changes in knowledge about peripheral neuropathy and/or lead to a groundbreaking discovery.
FPN Emerging Investigator Awardees
Chris Cashman, MD, PhD
2026 CRTS Recipient
Ariel Zhang, PhD
2026 CRTS Recipient
Tiffany Li, PhD
2025 CRTS Recipient
Francesco Michelassi, MD, PhD
2024 CRTS Recipient
Erika Williams, MD, PhD
2023 CRTS Recipient
Paula Barreras, MD
2023 CRTS Recipient
Program Eligibility
To be eligible for the award, applicants must:
- Be research investigators with an MD, PhD, or equivalent terminal-level clinical or research degree.
- Have completed clinical residency or PhD on or after July 1, 2022.
- Be at accredited US and international institutions are eligible to apply. There is no citizenship requirement.
- Have at least 50% time dedicated to research (protected time)
- Demonstrate a commitment to the field of peripheral neuropathy.
Application Process Dates
In terms of the application process, the dates for the current cylce are:
- July 1, 2026 – Applications open
- October 8, 2026, 5PM CT – Applications close
- Mid-January, 2027– Review day
- Mid-February, 2027 – Recipients notified
- July 1, 2027 – Funding to new recipients begins
